leisure time -WSS

leisure time

author：entertainment 2025-09-02 09:55:45 - browse：75

gantenerumab Alzheimer's disease Roche — Sebastien Bozon/AFP via Getty Images

LONDON — Roche on Thursday said its recently acquired experimental obesity medication helped people lose a significant amount of weight in an early trial, sending its shares up in early trading.

The drug, a once-weekly injection known as CT-388, resulted in an average placebo-adjusted weight loss of 18.8% after 24 weeks, the company said. The study was a Phase 1 trial, though it was placebo-controlled.

The reaction to such an early result — Roche shares were up roughly 4% early Thursday — is a signal both of the stakes of the obesity medication race and the keen interest investors have in the field.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Dark money group runs ads on China biotech bill

entertainment

WSS

Insmed lung disease drug hits target in key Phase 3 trial

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Boston hospital trains restaurant workers on naloxone for overdoses

Heat waves linked to early deliveries, preterm births in new study

Boston hospital trains restaurant workers on naloxone for overdoses

WuXi Biologics execs register to lobby as Congress comes for the company

entertainment

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Wikipedia

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Lab trade group sues FDA to halt regulation of lab

After affirmative action ruling, medical educators look to 'holistic review'

Lab trade group sues FDA to halt regulation of lab

Trump demands the U.S. pay no more for drugs than other countries … again

Fertility clinic egg and embryo storage is a disaster

Peter Hotez and the public health issue of online harassment

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

Affirmative action in medical school literally saved lives

Insmed lung disease drug hits target in key Phase 3 trial

entertainment

HHS suspends federal funding for EcoHealth Alliance

Heat waves linked to early deliveries, preterm births in new study

HHS suspends federal funding for EcoHealth Alliance

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

The United States must get value

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

hotspot

focus

entertainment

focus